| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.33 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |